Structure-Activity Relationships of Daptomycin Lipopeptides

Journal of Medicinal Chemistry
John A KarasTony Velkov

Abstract

Daptomycin is a calcium-dependent cyclic lipodepsipeptide derived from the soil saprotroph Streptomyces roseosporus, and its antibiotic properties make it a key agent for treatment of drug-resistant Gram-positive infections. It is most commonly used clinically for the treatment of Gram-positive skin and skin structure infections (SSSI), Staphylococcus aureus bacteremia, and right-sided endocarditis infections associated with S. aureus, including methicillin resistant S. aureus (MRSA). It has also been used "off-label" for Enterococcal infections. There has been a tremendous amount of research investigating its mode of action, resistance mechanisms, and biosynthesis of this clinically important antimicrobial agent. Although we cover the latter aspects in detail, the primary focus of this review is to provide the most comprehensive and up-to-date reference for the medicinal chemist on the structure-activity-toxicity of this important class of lipopeptide antibiotics.

References

Nov 11, 1991·Antimicrobial Agents and Chemotherapy·W E AlbornD A Preston
Dec 11, 1991·Antimicrobial Agents and Chemotherapy·N E AllenJ N Hobbs
Jan 1, 1990·Chemotherapy·A Digranes, E Benonisen
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·P CanepariG Satta
Aug 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J I Blenkharn, J H Darrell
Jul 1, 1987·Antimicrobial Agents and Chemotherapy·N E AllenW E Alborn
Feb 1, 1987·European Journal of Clinical Microbiology·R L HodinkaP H Gilligan
Feb 1, 1987·European Journal of Clinical Microbiology·F Ehlert, H C Neu
Feb 1, 1987·European Journal of Clinical Microbiology·J H JorgensenJ S Redding
Feb 1, 1987·European Journal of Clinical Microbiology·K Machka, I Braveny
May 17, 2001·Antimicrobial Agents and Chemotherapy·J A SilvermanT Li
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Jared A SilvermanHoward M Shapiro
Nov 19, 2003·Bioorganic & Medicinal Chemistry Letters·Jason HillJohn Finn
Nov 19, 2003·Bioorganic & Medicinal Chemistry Letters·James SiedleckiJohn Finn
Feb 19, 2004·Drugs·Caroline FentonMonique P Curran
Feb 27, 2004·The Journal of Antimicrobial Chemotherapy·Jennifer M StreitHelio S Sader
Jul 1, 2004·International Journal of Antimicrobial Agents·Ad C FluitDana Milatovic
Jul 1, 2004·Organic & Biomolecular Chemistry·Lee-Jon BallVasudevan Ramesh
Jul 24, 2004·Chemistry & Biology·Jason Micklefield
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Thorsten MascherJohn D Helmann
Nov 16, 2004·Diagnostic Microbiology and Infectious Disease·Helio S SaderRonald N Jones
Dec 23, 2004·Journal of the American Chemical Society·Jan GrünewaldMohamed A Marahiel
Jan 11, 2005·Clinical Therapeutics·LilyAnn Jeu, Horatio B Fung
Feb 12, 2005·The Journal of Antimicrobial Chemotherapy·Judith N SteenbergenFrancis P Tally
Jul 5, 2005·Expert Opinion on Investigational Drugs·F P TallyF B Oleson
Nov 29, 2005·Natural Product Reports·Richard H BaltzStephen K Wrigley
Mar 10, 2006·Microbiology and Molecular Biology Reviews : MMBR·Jan Grünewald, Mohamed A Marahiel
May 26, 2006·Antimicrobial Agents and Chemotherapy·Lisa FriedmanJared A Silverman
Sep 12, 2006·International Journal of Antimicrobial Agents·Glenn W KaatzSusan M Seo
Nov 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kien T NguyenRichard H Baltz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.